---
figid: PMC2759974__nihms132022f1
figlink: /pmc/articles/PMC2759974/figure/F1/
number: Figure 1
caption: 'HER2/neu is an orphan receptor that can be activated by overexpression or
  mutation of the transactivating domain (rat neu). Overexpression of HER2/neu results
  in enhanced cell survival and mitogenicity and its deregulation can lead to breast
  tumorigenesis. Erk activation by the Ras–Raf pathway leads to cell proliferation
  through the activation of a number of nuclear targets. Activation of the PI3K–Akt
  pathway results in enhanced survival through inhibition of proapoptosis proteins,
  such as Bad, GSK3 and the transcription factor FKHR-L1. A major mitogenic player
  acting downstream of ErbB2 is cyclin D1 []. Once bound by Wnt, the Frizzled/LDL-related
  protein (LRP) coreceptor complex activates the canonical signaling pathway. Frizzled
  interacts with Dsh, a cytoplasmic protein that functions upstream of β-catenin and
  the kinase GSK3β. Wnt signaling controls phosphorylation of Dsh. Wnts are thought
  to induce the phosphorylation of LRP by GSK3β and CK1γ, thus regulating the docking
  of Axin. The recruitment of Axin away from the destruction complex leads to the
  stabilization of β-catenin. In the nucleus, β-catenin displaces Groucho from Tcf/Lef
  to promote the transcription of Wnt target genes, one of which is cyclin D1. As
  indicated, a number of pathways lead from the receptors to enhanced activation of
  cyclin D1, thereby promoting cell cycle progression. c-Myc is one of the direct
  targets of E2Fs. Although both c-Myc and cyclin D1 rescue the CSF-1 response and
  regulate each other [], MMTV-Myc-induced breast cancer development is not dependent
  on cyclin D1 []. Dmp1 is a unique transcription factor that regulates the Arf-Mdm2-p53
  tumor surveillance pathway [–].APC: Adenomatosis polyposis coli; Cdc25: Cell division
  cycle 25; Dsh: Dishevelled; DHFR: Dihydrofolate reductase; GSK3β: Glycogen synthase
  kinase 3β; IKK: IκB kinase; LEF: Lymphoid enhancer-binding factor; Polα: DNA polymerase
  α; TCF: T-cell factor; TK: Thymidine kinase; TS: Thymidylate synthase.'
pmcid: PMC2759974
papertitle: MMTV mouse models and the diagnostic values of MMTV-like sequences in
  human breast cancer.
reftext: Pankaj Taneja, et al. Expert Rev Mol Diagn. ;9(5):423-440.
pmc_ranked_result_index: '26595'
pathway_score: 0.9596497
filename: nihms132022f1.jpg
figtitle: MMTV mouse models and the diagnostic values of MMTV-like sequences in human
  breast cancer
year: ''
organisms: Homo sapiens
ndex: 768f8838-dee0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2759974__nihms132022f1.html
  '@type': Dataset
  description: 'HER2/neu is an orphan receptor that can be activated by overexpression
    or mutation of the transactivating domain (rat neu). Overexpression of HER2/neu
    results in enhanced cell survival and mitogenicity and its deregulation can lead
    to breast tumorigenesis. Erk activation by the Ras–Raf pathway leads to cell proliferation
    through the activation of a number of nuclear targets. Activation of the PI3K–Akt
    pathway results in enhanced survival through inhibition of proapoptosis proteins,
    such as Bad, GSK3 and the transcription factor FKHR-L1. A major mitogenic player
    acting downstream of ErbB2 is cyclin D1 []. Once bound by Wnt, the Frizzled/LDL-related
    protein (LRP) coreceptor complex activates the canonical signaling pathway. Frizzled
    interacts with Dsh, a cytoplasmic protein that functions upstream of β-catenin
    and the kinase GSK3β. Wnt signaling controls phosphorylation of Dsh. Wnts are
    thought to induce the phosphorylation of LRP by GSK3β and CK1γ, thus regulating
    the docking of Axin. The recruitment of Axin away from the destruction complex
    leads to the stabilization of β-catenin. In the nucleus, β-catenin displaces Groucho
    from Tcf/Lef to promote the transcription of Wnt target genes, one of which is
    cyclin D1. As indicated, a number of pathways lead from the receptors to enhanced
    activation of cyclin D1, thereby promoting cell cycle progression. c-Myc is one
    of the direct targets of E2Fs. Although both c-Myc and cyclin D1 rescue the CSF-1
    response and regulate each other [], MMTV-Myc-induced breast cancer development
    is not dependent on cyclin D1 []. Dmp1 is a unique transcription factor that regulates
    the Arf-Mdm2-p53 tumor surveillance pathway [–].APC: Adenomatosis polyposis coli;
    Cdc25: Cell division cycle 25; Dsh: Dishevelled; DHFR: Dihydrofolate reductase;
    GSK3β: Glycogen synthase kinase 3β; IKK: IκB kinase; LEF: Lymphoid enhancer-binding
    factor; Polα: DNA polymerase α; TCF: T-cell factor; TK: Thymidine kinase; TS:
    Thymidylate synthase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APC
  - AKT2
  - NFKB1
  - MAP2K1
  - IKBKB
  - CHUK
  - ERBB2
  - AXIN1
  - AKT1
  - MDM2
  - CCNE1
  - CDC25A
  - FZD4
  - FZD6
  - AXIN2
  - MAP2K2
  - GSK3B
  - PIK3R5
  - CDKN2A
  - AKT3
  - REL
  - CCND1
  - PIK3CD
  - PIK3CG
  - FZD3
  - FZD1
  - POLA1
  - CTNNB1
  - CDKN1A
  - PIK3R6
  - FZD9
  - CDK4
  - MYC
  - PIK3CA
  - PIK3CB
  - JUN
  - FZD10
  - CCNE2
  - PIK3R3
  - MAPK3
  - RAF1
  - FZD7
  - FZD8
  - ETS2
  - FOS
  - PIK3R4
  - TP53
  - FZD5
  - HRAS
  - WNT1
  - DHFR
  - DMP1
  - FZD2
  - KRAS
  - MAPK1
  - ETS1
  - BRAF
  - NRAS
  - ARAF
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
genes:
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: NF-KB/IkB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: IKK1/IKK2
  symbol: IKK2
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK1/IKK2
  symbol: IKK1
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: HER2/neu
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Mdm2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: CyclinE,Pola,
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: Cdc25A
  symbol: CDC25A
  source: hgnc_symbol
  hgnc_symbol: CDC25A
  entrez: '993'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: GSK-3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: HER2/neu
  symbol: NEU
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Ink4a
  symbol: INK4a
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: c-Rel
  symbol: c-Rel
  source: hgnc_alias_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: CyclinE,Pola,
  symbol: POLA
  source: hgnc_prev_symbol
  hgnc_symbol: POLA1
  entrez: '5422'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: p21cip1
  symbol: p21CIP1
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN1A
  entrez: '1026'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: Cdk4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Fos/Jun/Ets
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: CyclinE,Pola,
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: Fos/Jun/Ets
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS2
  entrez: '2114'
- word: Fos/Jun/Ets
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Wnt1
  symbol: WNT1
  source: hgnc_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: DHFR,TK,TS,etc.
  symbol: DHFR
  source: hgnc_symbol
  hgnc_symbol: DHFR
  entrez: '1719'
- word: Dmp1
  symbol: DMP1
  source: hgnc_symbol
  hgnc_symbol: DMP1
  entrez: '1758'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Fos/Jun/Ets
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
